(Q44589038)

English

Pharmacokinetics and the most suitable dosing regimen of fluconazole in critically ill patients receiving continuous hemodiafiltration

scientific article published on 13 September 2003

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

4 December 2017

Pharmacokinetics and the most suitable dosing regimen of fluconazole in critically ill patients receiving continuous hemodiafiltration (English)

1 reference

Europe PubMed Central

PubMed publication ID

4 December 2017

1 reference

based on heuristic

inferred from title

pharmacokinetics

1 reference

based on heuristic

inferred from title

hemodiafiltration

1 reference

based on heuristic

inferred from title

author name string

Kazuaki Yagasaki

1

1 reference

Europe PubMed Central

PubMed publication ID

4 December 2017

Satoshi Gando

2

1 reference

Europe PubMed Central

PubMed publication ID

4 December 2017

Naoyuki Matsuda

3

1 reference

Europe PubMed Central

PubMed publication ID

4 December 2017

Takashi Kameue

4

1 reference

Europe PubMed Central

PubMed publication ID

4 December 2017

Toshiteru Ishitani

5

1 reference

Europe PubMed Central

PubMed publication ID

4 December 2017

Takeshi Hirano

6

1 reference

Europe PubMed Central

PubMed publication ID

4 December 2017

Ken Iseki

7

1 reference

Europe PubMed Central

PubMed publication ID

4 December 2017

publication date

13 September 2003

1 reference

Europe PubMed Central

PubMed publication ID

4 December 2017

Intensive Care Medicine

1 reference

Europe PubMed Central

PubMed publication ID

4 December 2017

29

1 reference

Europe PubMed Central

PubMed publication ID

4 December 2017

10

1 reference

Europe PubMed Central

PubMed publication ID

4 December 2017

1844-1848

1 reference

Europe PubMed Central

PubMed publication ID

4 December 2017

https://scigraph.springernature.com/pub.10.1007/s00134-003-1980-z

0 references

Activities of fluconazole (UK 49,858) and ketoconazole against ketoconazole-susceptible and -resistant Candida albicans

1 reference

https://pubmed.ncbi.nlm.nih.gov/13680113

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Pharmacokinetics of fluconazole in patients undergoing continuous ambulatory peritoneal dialysis

1 reference

https://pubmed.ncbi.nlm.nih.gov/13680113

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Effective fluconazole therapy for liver transplant recipients during continuous hemodiafiltration

1 reference

https://pubmed.ncbi.nlm.nih.gov/13680113

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Clinical pharmacokinetics of fluconazole

1 reference

https://pubmed.ncbi.nlm.nih.gov/13680113

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A pharmacokinetic analysis program (multi) for microcomputer

1 reference

https://pubmed.ncbi.nlm.nih.gov/13680113

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Clinical pharmacokinetics of fluconazole in superficial and systemic mycoses.

1 reference

https://pubmed.ncbi.nlm.nih.gov/13680113

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A randomized trial comparing fluconazole with amphotericin B for the treatment of candidemia in patients without neutropenia. Candidemia Study Group and the National Institute

1 reference

https://pubmed.ncbi.nlm.nih.gov/13680113

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

High-performance liquid chromatographic determination of fluconazole in plasma

1 reference

https://pubmed.ncbi.nlm.nih.gov/13680113

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Influence of continuous veno-venous haemodiafiltration and continuous veno-venous haemofiltration on the pharmacokinetics of fluconazole

1 reference

https://pubmed.ncbi.nlm.nih.gov/13680113

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Fluconazole. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential in superficial and systemic mycoses

1 reference

https://pubmed.ncbi.nlm.nih.gov/13680113

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Pharmacokinetics of fluconazole in renal failure

1 reference

https://pubmed.ncbi.nlm.nih.gov/13680113

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Fluconazole penetration into the pancreas

1 reference

https://pubmed.ncbi.nlm.nih.gov/13680113

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Pharmacokinetics of 18F-labeled fluconazole in healthy human subjects by positron emission tomography

1 reference

https://pubmed.ncbi.nlm.nih.gov/13680113

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Antifungal pharmacodynamic characteristics of fluconazole and amphotericin B tested against Candida albicans.

1 reference

https://pubmed.ncbi.nlm.nih.gov/13680113

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1007/S00134-003-1980-Z

1 reference

Europe PubMed Central

PubMed publication ID

4 December 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

4 December 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q44589038&oldid=2165698499"